Share This Page
Drug Price Trends for HM IODIDES TINCTURE
✉ Email this page to a colleague
Average Pharmacy Cost for HM IODIDES TINCTURE
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| HM IODIDES TINCTURE | 62011-0116-01 | 0.07220 | ML | 2025-12-17 |
| HM IODIDES TINCTURE | 62011-0116-01 | 0.07220 | ML | 2025-11-19 |
| HM IODIDES TINCTURE | 62011-0116-01 | 0.07220 | ML | 2025-10-22 |
| HM IODIDES TINCTURE | 62011-0116-01 | 0.07227 | ML | 2025-09-17 |
| HM IODIDES TINCTURE | 62011-0116-01 | 0.07241 | ML | 2025-08-20 |
| HM IODIDES TINCTURE | 62011-0116-01 | 0.07191 | ML | 2025-07-23 |
| HM IODIDES TINCTURE | 62011-0116-01 | 0.07098 | ML | 2025-06-18 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Market Analysis and Price Projections for HM Iodides Tincture
Introduction
HM Iodides Tincture is a pharmaceutical preparation that leverages iodine compounds for medical applications, primarily in the treatment of thyroid-related disorders and certain acute infections. Its market landscape is shaped by evolving regulatory environments, demographic shifts, clinical guidelines, and emerging alternatives. This report comprehensively analyzes the current market dynamics and offers price projections based on industry trends, manufacturing considerations, and competitive pressures.
Product Overview
HM Iodides Tincture combines iodine-based compounds, chiefly potassium iodide, in an alcohol-based tincture. Its therapeutic indications include management of hyperthyroidism, prophylaxis against radioactive iodine uptake, and treatment of certain cutaneous infections. Historically, iodine tinctures have enjoyed longstanding use, but recent innovations and alternative therapies have impacted demand.
Market Landscape
Global Market Size and Growth
The global demand for thyroid medications, including iodine solutions, is estimated at approximately USD 750 million in 2022, with a compound annual growth rate (CAGR) of 2.5% projected through 2028. The relatively stable demand stems from the persistent prevalence of thyroid disorders across demographics, especially in aging populations in North America and Europe.
Regional Market Dynamics
- North America: Dominates the market due to high healthcare expenditure and established diagnostic and treatment protocols for thyroid disorders. The U.S. accounts for nearly 40% of the global iodine tincture market.
- Europe: Exhibits steady growth driven by increased screening and diagnosis of thyroid conditions.
- Asia-Pacific: Represents the fastest-growing segment, with a CAGR of 4%, fueled by rising awareness, improving healthcare infrastructure, and higher thyroid disorder prevalence in countries like China and India.
- Latin America and Middle East: Moderate growth owing to expanding healthcare coverage.
Key Market Drivers
- Aging Population: Increased incidence of thyroid disorders in older adults sustains demand.
- Prophylactic Use: Nuclear safety protocols and radiological concerns bolster demand for iodine-based prophylactics.
- Regulatory Approvals: Approval of HM Iodides Tincture in emerging markets amplifies market reach.
- Clinical Adoption: Integration into treatment guidelines enhances utilization.
Competitive Landscape
Major players include Pfizer, Boehringer Ingelheim, and local generic manufacturers. Proprietary formulations and price competition are prevalent, with generics capturing significant market share.
Supply Chain and Manufacturing Trends
Manufacturing costs have remained relatively stable, influenced by iodine commodity prices and regulatory compliance costs. Scaling up manufacturing to meet regional demand necessitates adherence to Good Manufacturing Practices (GMP) and supply chain resilience.
Regulatory Environment
In developed markets, HM Iodides Tincture registration necessitates compliance with stringent pharmacovigilance and labeling standards. Variations across jurisdictions influence market entry strategies and pricing.
Price Trends and Projections
Current Pricing Landscape
- United States: Retail prices for 100 mL bottles range between USD 8 and USD 12, depending on packaging and supplier.
- Europe: Prices average EUR 7 to EUR 10 per 100 mL, with variations based on market and regulatory environment.
- Asia-Pacific: Prices are lower, often USD 3 to USD 6, attributable to local manufacturing and less stringent regulations.
Factors Affecting Price Dynamics
- Generic Competition: Elevated with multiple manufacturers producing HM Iodides Tincture, exerting downward pressure.
- Regulatory Costs: Stringent standards can inflate costs, impacting ex-factory prices.
- Raw Material Costs: Fluctuations in iodine commodity prices influence manufacturing costs.
- Healthcare Policy Changes: Reimbursement policies affect consumer prices, especially in government-funded systems.
Price Projection (2023–2028)
Based on industry analysis and market trends:
| Year | Estimated Price Range per 100 mL (USD) | Key Drivers |
|---|---|---|
| 2023 | USD 8 – USD 12 | Stable demand; moderate competition |
| 2024 | USD 7.50 – USD 11 | Increased generic competition; raw material stabilization |
| 2025 | USD 7 – USD 10 | Regulatory normalization; price erosion among generics |
| 2026 | USD 6.50 – USD 9.50 | Market saturation; rising raw material costs limit downward movement |
| 2027 | USD 6 – USD 9 | Price stabilization; potential for premium formulations |
| 2028 | USD 6 – USD 8.50 | Market consolidation; increasing global demand in emerging markets |
The forecast anticipates a gradual decline in prices driven by generic competition and manufacturing efficiencies, balanced against potential price stabilization through demand growth and emerging markets.
Opportunities and Challenges
Opportunities
- Expansion into Emerging Markets: Increasing healthcare investments in Asia and Latin America can broaden sales.
- Product Differentiation: Developing formulations with improved stability, dosing, or combination therapies can command premium pricing.
- Regulatory Approvals for New Indications: Broader indications could drive demand and justify higher prices.
Challenges
- Generic Price Erosion: Heightened competition limits pricing power.
- Regulatory Barriers: Variability across countries complicates market entry.
- Alternatives and Competition: Availability of other iodine preparations and synthetic alternatives challenge market share.
Regulatory and Competitive Strategies
Producers should prioritize regulatory compliance and procurement strategies that balance quality with affordability. Strategic alliances with local distributors can facilitate market penetration. Emphasis on clinical efficacy and safety profiles enhances competitive positioning.
Key Takeaways
- The global HM Iodides Tincture market is stable with modest growth, primarily driven by demographic trends and prophylactic applications.
- Price projections indicate a gradual decline to around USD 6–8.50 per 100 mL by 2028, mainly due to generic competition and cost efficiencies.
- Emerging markets offer significant growth opportunities, although regulatory complexities pose challenges.
- Maintaining quality standards and pursuing product innovation can sustain margins and market relevance.
- Competitive positioning requires balancing affordable pricing with regulatory compliance, manufacturing scalability, and strategic marketing.
FAQs
1. What is the primary therapeutic use of HM Iodides Tincture?
It is mainly used for treating hyperthyroidism, preventing radioactive iodine absorption, and managing iodine deficiency.
2. How does the entry of generic manufacturers impact prices?
Increased generic competition exerts downward pressure on prices, leading to more affordable options for healthcare providers and consumers.
3. What factors influence manufacturing costs for HM Iodides Tincture?
Raw iodine commodity prices, regulatory compliance costs, raw material sourcing logistics, and manufacturing scale.
4. Which regions present the fastest growth opportunities?
The Asia-Pacific region exhibits the highest growth potential due to rising healthcare infrastructure and increased disease prevalence.
5. How might regulatory changes impact global pricing?
Stricter regulations may increase compliance costs, raising wholesale prices, but can also reduce market entry for substandard products, potentially stabilizing prices.
References
[1] Global Market Insights. “Thyroid Disorder Treatment Market Report 2022.”
[2] IQVIA. “Pharmaceutical Pricing Data 2022.”
[3] WHO. “Thyroid Disease Prevalence and Trends.”
[4] MarketsandMarkets. “Iodine Market by Application and Region, 2022–2028.”
[5] U.S. FDA. “Regulatory Guidelines for Pharmaceutical Products,” 2022.
More… ↓
